
Liquidia Corporation
Liquidia Corporation (LQDA) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · LQDA · as of Mar 31, 2025
Ownership Breakdown
181
Institutional Holders
$808.02M
Total Inst. Value
▲ $171.89M vs Q4
88.93M
Shares Outstanding
freeFloat 70.42%
54.74M
13F Shares Held
▲ 1.26M vs Q4
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
LQDA largest shareholders · institutional ownership
Q1 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
CALIGAN PARTNERS LP pharmaceutical preparations | 8.12M | 9.53% | 9.53% | $119.75B | May 15, 2025 | — held |
BLACKROCK, INC. pharmaceutical preparations | 4.73M | 5.56% | 5.56% | $69.80B | May 2, 2025 | ▲ 70.4K |
FARALLON CAPITAL MANAGEMENT LLC pharmaceutical preparations | 3.99M | 4.69% | 4.69% | $58.87B | May 15, 2025 | ▲ 700.0K |
VANGUARD GROUP INC pharmaceutical preparations | 3.47M | 4.07% | 4.07% | $51.13B | May 9, 2025 | ▼ 90.7K |
FINDELL CAPITAL MANAGEMENT LLC pharmaceutical preparations | 2.89M | 3.39% | 3.39% | $42.63B | May 15, 2025 | ▼ 190.0K |
OPALEYE MANAGEMENT INC. pharmaceutical preparations | 2.26M | 2.65% | 2.65% | $33.34B | May 15, 2025 | ▲ 561.9K |
STATE STREET CORP pharmaceutical preparations | 1.79M | 2.10% | 2.10% | $26.37B | May 15, 2025 | ▼ 24.0K |
JANUS HENDERSON GROUP PLC pharmaceutical preparations | 1.64M | 1.92% | 1.92% | $24.73B | May 15, 2025 | ▲ 1.10M |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) pharmaceutical preparations | 1.62M | 1.90% | 1.90% | $23.85B | May 15, 2025 | NEW |
PATIENT SQUARE CAPITAL LP pharmaceutical preparations | 1.52M | 1.79% | 1.79% | $22.46B | May 14, 2025 | ▼ 337.9K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q1 2025 vs prior quarter
Q1 2025
23
Increased
+6.29M shares3
New Positions
first time holders17
Decreased
−4.32M shares0
Sold Out
fully exitedNet shares change (top 50)
+1.97M
+6.29M / −4.32M
Net new holders
+9
3 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
LQDA insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
26
Buy transactions
71
Sell transactions
0.37
Buy/Sell ratio
$2M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
JEFFS ROGER Chief Executive Officer | May 27, 2026 | Sale | 6,428 | $62.18 | $399.7K | 1.04M | Form 4 ↗ |
SINGH RAMAN director | May 21, 2026 | Sale | 29,494 | $60.13 | $1.77M | 38.8K | Form 4 ↗ |
JEFFS ROGER Chief Executive Officer | May 21, 2026 | Sale | 25,000 | $61.13 | $1.53M | 1.10M | Form 4 ↗ |
JEFFS ROGER Chief Executive Officer | May 22, 2026 | Sale | 25,000 | $61.52 | $1.54M | 1.07M | Form 4 ↗ |
JEFFS ROGER Chief Executive Officer | May 26, 2026 | Sale | 25,000 | $60.38 | $1.51M | 1.05M | Form 4 ↗ |
Caligan Partners LP See Remarks | May 19, 2026 | Purchase | 5,300 | $59.98 | $317.9K | 8.14M | Form 4 ↗ |
Caligan Partners LP See Remarks | May 19, 2026 | Sale | 5,300 | $59.98 | $317.9K | 8.13M | Form 4 ↗ |
JEFFS ROGER Chief Executive Officer | May 18, 2026 | Sale | 25,000 | $56.77 | $1.42M | 1.17M | Form 4 ↗ |
JEFFS ROGER Chief Executive Officer | May 19, 2026 | Sale | 25,000 | $58.65 | $1.47M | 1.15M | Form 4 ↗ |
JEFFS ROGER Chief Executive Officer | May 20, 2026 | Sale | 25,000 | $61.30 | $1.53M | 1.12M | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Liquidia Corporation (LQDA) is primarily owned by institutional investors, who hold approximately 61.6% of total shares outstanding. Company insiders own approximately 29.58%, while retail and public investors account for the remaining 8.86%.
The largest institutional shareholder of Liquidia Corporation is CALIGAN PARTNERS LP, holding approximately 8.12 million shares — equal to 9.53% of outstanding shares — as of March 31, 2025.
A total of 181 institutional investors currently hold LQDA stock, with a combined institutional value of approximately $808,019,502 as of the most recent 13F filing period.
Frequently asked questions
LQDA ownershipLiquidia Corporation (LQDA) is primarily owned by institutional investors, who hold approximately 61.6% of shares. The largest shareholder is CALIGAN PARTNERS LP with a 9.53% stake. Company insiders hold 29.58%. Data sourced from SEC Form 13F as of March 31, 2025.